Period of time： 2003年4期
Publisher： Elsevier
Founded in： 2000
Total resources： 2
ISSN： 1567-5688
Subject： R5 Internal Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Atherosclerosis, Supplements,volume 4,issue 4
Menu
Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase
By Boger R.H., Vallance P., Cooke J.P. in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.
Access to resources
Recommend
Old and new cardiovascular risk factors: from unresolved issues to new opportunities
By Maas R., Boger R.H. in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.By Valkonen V.-P., Laakso J., Paiva H., Lehtimaki T., Lakka T.A., Isomustajarvi M., Ruokonen I., Salonen J.T., Laaksonen R. in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.By Boger R.H., Zoccali C. in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.By Mugge A., Hanefeld C., Boger R.H., CARDIAC study investigators in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.By Tran C.T.L., Leiper J.M., Vallance P. in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.By Sydow K., Munzel T. in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA
By Lentz S.R., Rodionov R.N., Dayal S. in (2003)
Atherosclerosis, Supplements,volume 4,issue 4 , Vol. 4, Iss. 4, 2003-12 , pp.